Amneal Pharmaceuticals (AMRX) Raw Materials (2017 - 2020)

Amneal Pharmaceuticals' Raw Materials history runs 4 years deep, the most recent figure standing at $162.7 million for Q1 2020.

• In Q1 2020, Raw Materials changed N/A year-over-year to $162.7 million; the TTM figure through Mar 2020 stood at $162.7 million (changed N/A YoY), while the FY2019 annual figure was $172.2 million, down 5.23% from the prior year.
• Raw Materials was $162.7 million for Q1 2020 at Amneal Pharmaceuticals, down from $172.2 million in the prior quarter.
• In the past five years, Raw Materials ranged from a high of $205.1 million in Q3 2018 to a low of $140.1 million in Q4 2017.
• Historically, Raw Materials has averaged $178.4 million across 4 years, with a median of $180.9 million in 2018.
• The sharpest annual moves came in 2018 and 2019: Raw Materials advanced 29.71% in 2018, then declined 11.13% in 2019.
• A 4-year view of Raw Materials shows it stood at $140.1 million in 2017, then rose by 29.71% to $181.7 million in 2018, then dropped by 5.23% to $172.2 million in 2019, then fell by 5.48% to $162.7 million in 2020.
• The last three Raw Materials figures came in at $162.7 million (Q1 2020), $172.2 million (Q4 2019), and $182.8 million (Q3 2019), per Business Quant data.